市场调查报告书
商品编码
1451782
2024-2032 年按产品类型、技术、应用、最终用户和地区分類的植入式给药装置市场报告Implantable Drug Delivery Devices Market Report by Product Type, Technology, Application, End User, and Region 2024-2032 |
2023年全球植入式给药装置市场规模达143亿美元。展望未来, IMARC Group预计到2032年市场规模将达到263亿美元,2024-2032年复合年增长率(CAGR)为6.81%。慢性病盛行率不断上升、对微创手术的需求不断增长、易患慢性疾病的老年人口不断增加,以及植入设备技术的快速进步是推动市场的一些关键因素。
植入式药物输送装置被植入体内,以便能够在较长时间内持续释放药物。这些设备的构造涉及几个关键组件,包括储库或含有药物的隔间、释放机构以及用于监测药物水平或生理参数并提供即时反馈的感测器。与传统的给药方法相比,植入式药物传递装置具有许多优点,例如维持血流中恆定的药物浓度并避免与口服药物相关的高峰和低谷。这确保了最佳的治疗水平并提高了患者的依从性。此外,这些设备可以编程为在特定的时间间隔释放药物,从而减少频繁给药的需要并提高患者的便利性。此外,植入式药物输送装置可实现局部药物输送,最大限度地减少全身副作用并提高治疗效果。目前,有多种类型的植入式药物输送装置,包括植入式泵,它利用电机驱动机构以受控的速率将药物从储库中推出。
全球植入式给药装置市场的成长主要受到多种因素的推动,包括癌症、糖尿病和心血管疾病等慢性病盛行率的不断上升。此外,对微创手术的需求不断增长,以及更容易患慢性疾病的老年人口不断增加,正在推动市场成长。此外,植入式设备的快速技术进步(例如可生物降解和可编程药物传输系统的开发)以及对长期治疗解决方案不断增长的需求正在推动市场成长。除此之外,降低医疗成本的需求不断增长以及有利的报销政策的提供正在推动市场的成长。据此,各国政府正在采取措施推广先进的医疗保健技术,这反过来又推动了市场的成长。旨在推出新颖和创新的植入式药物输送设备的新兴研发(R&D)活动也正在推动市场扩张。其他因素,例如人们对植入式药物输送装置的好处的认识不断增强,以及对个人化医疗和标靶药物输送的日益关注,也促进了市场的成长。
The global implantable drug delivery devices market size reached US$ 14.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.81% during 2024-2032. The increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, the growing geriatric population susceptible to chronic disorders, and rapid technological advancements in implantable devices are some of the key factors driving the market.
Implantable drug delivery devices are implanted within the body to enable the sustained release of drugs over an extended period. The construction of these devices involves several key components, including a reservoir or a drug-containing compartment, a release mechanism, and sensors to monitor drug levels or physiological parameters, providing real-time feedback. Implantable drug delivery devices offer numerous advantages over conventional drug administration methods, such as maintaining a constant drug concentration in the bloodstream and avoiding the peaks and troughs associated with oral medications. This ensures optimal therapeutic levels and improves patient compliance. Furthermore, these devices can be programmed to release drugs at specific intervals, reducing the need for frequent dosing and improving convenience for patients. Additionally, implantable drug delivery devices enable localized drug delivery, minimizing systemic side effects and enhancing the efficacy of treatment. Currently, there are various types of implantable drug delivery devices available, including implantable pump, which utilizes a motor-driven mechanism to push the drug out of the reservoir at a controlled rate.
The global implantable drug delivery devices market is primarily accelerated by various factors, including the escalating prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Moreover, the rising demand for minimally invasive procedures and the growing geriatric population, which is more susceptible to chronic illnesses, are driving the market growth. Additionally, rapid technological advancements in implantable devices, such as the development of biodegradable and programmable drug delivery systems, and the escalating demand for long-term therapeutic solutions are fueling the market growth. Besides this, the escalating need to reduce healthcare costs and the availability of favorable reimbursement policies are bolstering the market growth. In line with this, governments of various nations are undertaking initiatives to promote advanced healthcare technologies, which, in turn, is propelling the market growth. The burgeoning research and development (R&D) activities aimed at introducing novel and innovative implantable drug delivery devices are also driving market expansion. Other factors, such as the growing awareness about the benefits of implantable drug delivery devices and enhancing focus on personalized medicine and targeted drug delivery, are contributing to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global implantable drug delivery devices market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, technology, application, and end user.
Implantable Drug Eluting Stents
Implantable Contraceptive Drug Delivery Devices
Implantable Intraocular Drug Delivery Devices
Implantable Brachytherapy Seeds Devices
Implantable Drug Delivery Pump Devices
The report has provided a detailed breakup and analysis of the implantable drug delivery devices market based on the product type. This includes implantable drug eluting stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable brachytherapy seeds devices, and implantable drug delivery pump devices. According to the report, implantable drug eluting stents represented the largest segment.
Biodegradable Implants
Non-Biodegradable Implants
A detailed breakup and analysis of the implantable drug delivery devices market based on technology has also been provided in the report. This includes biodegradable and non-biodegradable implants. According to the report, non-biodegradable implants accounted for the largest market share.
Oncology
Cardiovascular
Autoimmune Diseases
Obstetrics and Gynecology
Others
The report has provided a detailed breakup and analysis of the implantable drug delivery devices market based on the application. This includes oncology, cardiovascular, autoimmune diseases, obstetrics and gynecology, and others. According to the report, cardiovascular represented the largest segment.
Hospitals
Ambulatory Surgery Centers
Others
A detailed breakup and analysis of the implantable drug delivery devices market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for implantable drug delivery devices. Some of the factors driving the North America implantable drug delivery devices market included the expanding pharmaceutical industry, the emergence of new drug delivery techniques, the availability of skilled healthcare professionals, and the establishment of specialized clinics and hospitals.
The report has also provided a comprehensive analysis of the competitive landscape in the global implantable drug delivery devices market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Boston Scientific Corporation, Delpor Inc., Koninklijke DSM N.V., Medtronic plc, Theragenics Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.